MASLD (Fatty Liver Disease): A Silent Epidemic in the U.S.

Fatty liver disease—now renamed Metabolic dysfunction‑associated steatotic liver disease (MASLD)—is a growing health crisis in the United States. Affecting 25% to 33% of American adults, MASLD is closely linked to obesity, type 2 diabetes, and metabolic syndrome. Often symptomless until advanced stages, MASLD is a silent epidemic that requires early detection and proactive management. What […]